Adicet Bio to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Adicet Bio, a biotechnology firm focused on innovative gamma delta T cell therapies, announced participation in two virtual investor conferences. The first is the UBS Global Healthcare Virtual Conference from May 24-26, where CEO Chen Schor will present on May 26 at 7:00 AM ET. The second event is the JMP Securities Life Sciences Conference on June 16-17, featuring a fireside chat with Schor on June 16 at 3:00 PM ET. Live webcasts will be available on their website, with replays accessible for 30 days post-event.

MENLO PARK, Calif., May 18, 2021 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases, today announced that company management will participate in two upcoming virtual investor conferences in May and June.

Details of the events are as follows:

UBS Global Healthcare Virtual Conference, May 24-26, 2021
Chen Schor, President and Chief Executive Officer, will present on Wednesday, May 26, 2021, at 7:00 AM ET.

The JMP Securities Life Sciences Conference, June 16-17, 2021
Chen Schor, President and Chief Executive Officer, will participate in a fireside chat on Wednesday, June 16, 2021 at 3:00 PM ET.

Live audio webcasts of the presentations can be accessed on the Investors section of Adicet Bio’s website at https://investor.adicetbio.com. An archived replay will be available for 30 days following the presentation.

About Adicet Bio, Inc.
Adicet Bio, Inc. is a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet is advancing a pipeline of “off-the-shelf” gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients. For more information, please visit our website at http://www.adicetbio.com.

Adicet Bio., Inc.
Investor and Media Contacts

Anne Bowdidge
abowdidge@adicetbio.com 

Janhavi Mohite
Stern Investor Relations, Inc.
212-362-1200
janhavi.mohite@sternir.com 

FAQ

When will Adicet Bio participate in the UBS Global Healthcare Virtual Conference?

Adicet Bio will participate in the UBS Global Healthcare Virtual Conference from May 24-26, 2021, with CEO Chen Schor presenting on May 26 at 7:00 AM ET.

What is the date of Chen Schor's fireside chat at the JMP Securities Life Sciences Conference?

Chen Schor's fireside chat at the JMP Securities Life Sciences Conference is scheduled for June 16, 2021, at 3:00 PM ET.

How can I access the webcasts of Adicet Bio's presentations?

Live audio webcasts of Adicet Bio's presentations can be accessed on the Investors section of their website. Archived replays will be available for 30 days after the presentations.

What are the upcoming investor conferences for Adicet Bio in 2021?

Adicet Bio is participating in the UBS Global Healthcare Virtual Conference from May 24-26 and the JMP Securities Life Sciences Conference on June 16-17, 2021.